Clinical, pathological and genetic characteristics of 8 patients with distal hereditary motor neuropathy.
- Author:
Mei Ge LIU
1
;
Pu FANG
2
;
Yan WANG
1
;
Lu CONG
1
;
Yang Yi FAN
1
;
Yuan YUAN
1
;
Yan XU
1
;
Jun ZHANG
1
;
Dao Jun HONG
1
Author Information
1. Department of Neurology, Peking University People's Hospital, Beijing 100044, China.
2. Department of Neurology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
- Publication Type:Journal Article
- Keywords:
Clinical manifestations;
Distal hereditary motor neuropathy;
Electromyography;
Gene;
Pathology
- MeSH:
Adolescent;
Adult;
Child;
Hereditary Sensory and Motor Neuropathy/genetics*;
Humans;
Middle Aged;
Mutation;
Peripheral Nervous System Diseases;
Phenotype;
Retrospective Studies;
Young Adult
- From:
Journal of Peking University(Health Sciences)
2021;53(5):957-963
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:Distal hereditary motor neuropathy (dHMN) comprises a heterogeneous group of inherited disorders associated with neurodegeneration of motor nerves and neurons, mainly charac-terized by progressive atrophy and weakness of distal muscle without clinical or electrophysiological sensory abnormalities. To improve the recognition and diagnosis of the disease, we summarized the clinical manifestations, electrophysiological, pathological, and genetic characteristics in eight patients with dHMN.
METHODS:Eight probands from different families diagnosed with dHMN were recruited in this study between June 2018 and April 2019 at Peking University People's Hospital. Eight patients underwent complete neurological examination and standard electrophysiological examinations. The clinical criteria were consistent with the patients presenting with a pure motor neuropathy with no sensory changes on electrophysiology. The detailed clinical symptoms, neurophysiological examinations, pathological features and gene mutations were analyzed retrospectively. Genetic testing was performed on the eight patients using targeted next-generation sequencing panel for inherited neuromuscular disorder and was combined with segregation analysis.
RESULTS:The age of onset ranged between 11 and 64 years (median 39.5 years) in our dHMN patients. All the cases showed a slowly progressive disease course, mainly characterized by distal limb muscle weakness and atrophy. The motor nerve conduction revealed decreased compound muscle action potential amplitude and velocity, while the sensory nerve conduction velocities and action potentials were not affected. Needle electromyography indicated neurogenic chronic denervation in all patients. Muscle biopsy performed in two patients demonstrated neurogenic skeletal muscle damage. Sural nerve biopsy was performed in one patient, Semithin sections shows relatively normal density and structure of large myelinated fibers, except very few fibers with thin myelin sheaths, which suggested very mild sensory nerve involvement. Eight different genes known to be associated with dHMN were identified in the patients by next-generation sequencing, pathogenic dHMN mutations were identified in three genes, and the detection rate of confirmed genetic diagnosis of dHMN was 37.5% (3/8). Whereas five variants of uncertain significance (VUS) were identified, among which two novel variants co-segregated the phenotype.
CONCLUSION:dHMN is a group of inherited peripheral neuropathies with great clinical and genetic heterogeneity. Next-generation sequencing is widely used to discover pathogenic genes in patients with dHMN, but more than half of the patients still remain genetically unknown.
